Einsfelder B M, Müller K-M
Institut für Pathologie der Ruhr-Universität Bochum an den Berufsgenossenschaftlichen Kliniken Bergmannsheil Bochum, Universitätsklinik.
Pathologe. 2005 May;26(3):169-77. doi: 10.1007/s00292-004-0709-2.
We report on three autopsy cases with clinical and morphological evidence of pulmonary hypertension and concurrent myeloproliferative disorders. Massive accumulations of pleomorphic, atypical megakaryocytes and thrombotic material are found within the pulmonary capillary beds. Morphometrical studies allowed us to identify on average 1,293.4 (1,145.8-1,401) megakaryocytes per one square centimetre lung tissue (standard value: 25 megakaryocytes/cm(2) lung tissue). The lungs of the controls with unaffected parenchyma show smaller numbers of megakaryocytes. It seems highly unlikely that these haematopoietic cells originate in lung capillaries in the absence of morphological correlates. Recurrent chronic microemboli consisting of megakaryocytes and thrombocytes could be held responsible for the development of secondary chronic pulmonary hypertension. Our observations suggest that pulmonary hypertension associated with chronic myeloproliferative disorders should be classified into the fourth group of the EVIAN-classification of pulmonary hypertension.
我们报告了三例尸检病例,这些病例具有肺动脉高压和并发骨髓增殖性疾病的临床及形态学证据。在肺毛细血管床内发现了大量多形性、非典型巨核细胞和血栓物质堆积。形态计量学研究使我们能够确定,每平方厘米肺组织平均有1293.4个(1145.8 - 1401个)巨核细胞(标准值:25个巨核细胞/平方厘米肺组织)。实质未受影响的对照组肺部巨核细胞数量较少。在缺乏形态学相关因素的情况下,这些造血细胞似乎极不可能起源于肺毛细血管。由巨核细胞和血小板组成的复发性慢性微栓子可能是继发性慢性肺动脉高压发展的原因。我们的观察结果表明,与慢性骨髓增殖性疾病相关的肺动脉高压应归类于肺动脉高压埃维昂分类的第四组。